Ningning Wu
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Orelabrutinib in combination with pomalidomide for the successful treatment of primary vitreoretinal lymphoma: a case report.
Journal: Frontiers in medicine
Published: February 07, 2026
Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome.
Journal: Frontiers in nutrition
Published: December 16, 2022
Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.
Journal: Annals of hematology
Published: December 06, 2022
Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome.
Journal: Cancer management and research
Published: February 25, 2022
MLL-SEPT5 Fusion Transcript in Myelodysplastic Syndrome Patient With t(11;22)(q23;q11).
Journal: Frontiers in medicine
Published: September 25, 2021
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia.
Journal: The Journal of international medical research
Published: January 08, 2019
Dynamic impact of inflammation-based indices in colorectal cancer patients receiving FOLFOX-based chemotherapy.
Journal: Cancer management and research
Published: October 24, 2018
SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.
Journal: Leukemia & lymphoma
Published: March 11, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026